Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia

J E Alexander1, A M Berry, J C Paton

  • 1Department of Microbiology and Immunology, University of Leicester, Leicester, LE1 9HN, U.K.

Insights

Pneumolysin, a Streptococcus pneumoniae toxin, has cytotoxic and complement-activating activities. Complement activation by pneumolysin significantly impacts lung behavior and bacteremia in mice during early infection.

Area of Science:

  • Microbiology
  • Immunology
  • Toxicology

Background:

  • Streptococcus pneumoniae causes pneumonia and bacteremia.
  • Pneumolysin is a key toxin produced by S. pneumoniae.
  • Pneumolysin exhibits both cytotoxic and complement-activating functions.

Purpose of the Study:

  • To investigate the distinct roles of pneumolysin's cytotoxic and complement-activating activities in S. pneumoniae virulence.
  • To determine which pneumolysin function is more critical for early infection outcomes in a mouse model.

Main Methods:

  • Generation of isogenic mutants of S. pneumoniae with altered pneumolysin activities.
  • Intranasal infection of mice with wild-type and mutant strains.
  • Assessment of bronchopneumonia, bacteremia, and bacterial behavior in the lungs.

Main Results:

  • Reducing either cytotoxic or complement-activating activity decreased pneumococcal virulence.
  • Complement activation by pneumolysin was found to be the primary driver of early lung pathology and bacteremia.
  • The effect of complement activation on virulence was most pronounced within the first 24 hours post-infection.

Conclusions:

  • Pneumolysin's complement-activating function is critical for the early stages of S. pneumoniae infection.
  • Targeting pneumolysin's complement activation may be a viable strategy to combat pneumococcal disease.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: